Search results
Grifols prepares for late-stage plans with plasma-derived medicines in 2024
Pharmaceutical Technology via Yahoo Finance· 5 days agoGrifols plans to release Phase III results of its long-term albumin treatment designed to increase ...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 5 days agoThe safety analysis showed that all patients suffered treatment-emergent adverse...associated...
Gateway - Jalopnik
Jalopnik· 4 days agoDrive free or die.
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoThat RS Rating means Pfizer stock ranks in the bottom 23% of all stocks in terms of performance over...
Raw milk health risks significantly outweigh any potential benefits − food scientists and...
The Conversation via Yahoo News· 3 days agoIt was written by: Juan Silva, Mississippi State University; Joel Komakech, Mississippi State...
Johnson & Johnson seeks FDA nod for new cancer treatment By Investing.com
Investing.com· 5 days agoFood and Drug Administration (FDA) for a subcutaneous formulation of amivantamab, aimed at treating...
Gateway - Quartz
Quartz· 4 days agoTupperware, a legacy brand in turmoil, is gearing up for a turnaround. It has finalized an agreement with its lenders to restructure its existing debt obligations, the food
Treatment of Blood Cancers
Digital Journal· 4 days agoVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the ...
State Fair of Texas shooting victim sues companies involved in security, suspected gunman
Dallas Morning News· 3 days agoA woman who was one of three people wounded in a shooting at the State Fair of Texas last year is...
Top 2024 Hillsborough grads plot path ahead for Florida amid rampant growth
Tampa Bay Times· 6 days agoThe explosion of growth in Florida since World War II has continually vexed planners, business...